Mineshkumar Patel

About

Patel Mineshkumar Ashvinkumar is working as an Assistant Professor, at the Department of Pharmacology, Saraswati Institute of Pharmaceutical Sciences, Gandhinagar, Gujarat. He Has published over 13 National and International Papers in reputed journals (SCI/ Scopus). He has held more than 13 Patents to date Granted. He has been associated with Quality Pharmacy Education as an Academician and Researcher for nine years. He has guided various students for their M. Pharm and Pharm. D. He has also published 5 Books in the Pharmacy discipline. He has received two International awards by Partially Govt. of Pondicherry. He serves as a Reviewer for many Elsevier’s, STM & Bentham Journals. He is also held BLS (Basic Life Supporter) Provider by the American Heart Association, USA. He is also an active Member of IPGA, APTI & ESMO.

Employment

• Saraswati Institute of Pharmaceutical Sciences Assistant Professor
  2022 - Present
• Shree Dhanvantry Pharmacy College Assistant Professor
  2020 - 2022
• Sat Kaival College of Pharmacy Assistant Professor
  2020 - 2020

Education

• Gujarat Technological University Pharmacovigilance
  2022 - 2033
• Parul University Doctor of Philosophy
  2020 - 2024
• Parul Institute of Pharmacy and Research Master of Pharmacy
  2018 - 2020
• Ganpat University Bachelor
  2014 - 2018

Projects & Funding

Projects & funding information is unavailable.

Publications (16)

• Exploring the Pharmacological & Therapeutic Potential of Monoamine Oxidase Inhibitors in Lung Cancer Treatment: Unearthing Novel Pathways for Clinical Advancement
  2023 DOI: 10.20944/preprints202310.1721.v1
  +Save
• Smart Dissolution Apparatus for Tablets & Capsules
  UK Intellectual Property Office 2023
  +Save
• T- Maze device for Detection of Locomotor activity in animals
  UK Intellectual Property Rights 2023
  +Save
• A novel iot-based hydrophone system for medicinal Tanacetum parthenium
  The President of the German Patent and Trademark Office 2023
  +Save
• CO55 Radiographic Progression-Free Survival (RPFS) as a Surrogate Endpoint for Overall Survival (OS) in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer (MCRPC): A Correlation Meta-Analysis
  Value in Health 2022 DOI: 10.1016/j.jval.2022.09.134
  +Save
• MSR18 Modeling and Comparison of Non-Disease-Related Survival (NDRS) Using Local Lifetables and Reported Trial Data: A Case Study From Adjuvant Treatment of Muscle-Invasive Urothelial Carcinoma (MIUC)
  Value in Health 2022 DOI: 10.1016/j.jval.2022.09.1750
  +Save
• Chronic gut inflammation impairs contextual control of fear
  Scientific Reports 2022 DOI: 10.1038/s41598-022-24901-3
  +Save
• Clinical Pharmacological Activity of Ayurvedic Treatments in an Osteoarthritis and it’s Benefits Outcomes: Ethnopharmacology Review
  Asian Journal of Pharmacy and Technology 2022 DOI: 10.52711/2231-5713.2022.00057
  +Save
• Phase 1b results from OP-1250-001, a dose escalation and dose expansion study of OP-1250, an oral CERAN, in subjects with advanced and/or metastatic estrogen receptor (ER)-positive, HER2-negative breast cancer (NCT04505826)
  European Journal of Cancer 2022 DOI: 10.1016/s0959-8049(22)00896-6
  +Save
• 453O DS-7300 (B7-H3 DXd antibody-drug conjugate [ADC]) shows durable antitumor activity in advanced solid tumors: Extended follow-up of a phase I/II study
  Animal of Oncology 2022 DOI: 10.1016/j.annonc.2022.07.582
  +Save